Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: News

Institutions to lead £1.7m-funded network to support people at risk of dementia

Institutions to lead £1.7m-funded network to support people at risk of dementia
p p Read More

The neurodegenerative condition currently affects more than 944,000 people in the UK

July 10, 2024 Dementia, Innovation and Involvement NETwork, News, Sustainable Prevention, University College London, University of Exeter

Francis Crick and ICL spinout raises £90m to clinically develop cancer treatments

Francis Crick and ICL spinout raises £90m to clinically develop cancer treatments
p p Read More

Myricx Bio’s therapies include treatments for breast, lung and colorectal cancer

July 9, 2024 ADCs, Francis Crick Institute, Imperial College London, Myricx Bio, News, Oncology

SMC accepts Boehringer/Lilly’s Jardiance for CKD within NHS Scotland

SMC accepts Boehringer/Lilly’s Jardiance for CKD within NHS Scotland
p p Read More

The serious, progressive kidney disease affects nearly 850 million people worldwide

July 9, 2024 Boehringer Ingelheim, chronic kidney disease, EMPA-KIDNEY, empagliflozin, Jardiance, News, NHS Scotland, Scottish Medicines Consortium

Coloplast launches digital leakage notification system Heylo for stoma patients

Coloplast launches digital leakage notification system Heylo for stoma patients
p p Read More

More than 176,000 people in the UK are living with a stoma, according to NHS data

July 8, 2024 Coloplast, Heylo, News, NHS, Stoma

Mission awarded $5.2m to advance potential Parkinson’s treatment

Mission awarded .2m to advance potential Parkinson’s treatment
p p Read More

The progressive neurodegenerative condition affects around 153,000 people in the UK

July 8, 2024 Michael J. Fox Foundation, Mission Therapeutics, MTX325, neurodegenerative diseases, News, Parkinson's disease, Parkinson’s UK

Study reveals mobile phone data can help map the spread of pathogens

Study reveals mobile phone data can help map the spread of pathogens
p p Read More

Pneumococcus is the leading cause of pneumonia, meningitis and sepsis worldwide

July 5, 2024 Global Pneumococcal Sequencing project, Infectious diseases, National Institute for Communicable Disease, News, Streptococcus pneumoniae, University of Cambridge, University of Witwatersrand, Wellcome Sanger Institute

NeuroSense Therapeutics shares positive results of lead candidate in ALS

NeuroSense Therapeutics shares positive results of lead candidate in ALS
p p Read More

The neurodegenerative disease currently affects more than 200,000 people worldwide

July 5, 2024 amyotrophic lateral sclerosis, bayer, Celebrex, celecoxib, ciprofloxacin, NeuroSense Therapeutics, News, PARADIGM, Pfizer, PrimeC

Study reveals genetic mutations associated with aggressive prostate cancer

Study reveals genetic mutations associated with aggressive prostate cancer
p p Read More

Aggressive prostate cancer accounts for up to 15% of all prostate cancer diagnoses

July 4, 2024 aggressive prostate cancers, Institute of Cancer Research, News, Oncology, prostate cancer, UK Genetic Prostate Cancer Study

Herantis Pharma granted €3.6m to assess treatment for Parkinson’s disease

Herantis Pharma granted €3.6m to assess treatment for Parkinson’s disease
p p Read More

The progressive neurological condition affects around 153,000 people in the UK

July 4, 2024 HER-096, Herantis Pharma, Michael J. Fox Foundation, News, Parkinson's disease, Parkinson's UK Virtual Biotech Programme

Study reveals cardiovascular health could be biggest risk factor for dementia

Study reveals cardiovascular health could be biggest risk factor for dementia
p p Read More

Dementias, including Alzheimer’s disease, are estimated to affect 944,000 people in the UK

July 3, 2024 Dementia, National Institute for Health and Care Research, News, NICE Three School's Dementia Research Programme, University College London

Posts navigation

Posts pagination

« Previous 1 … 39 40 41 … 66 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy